Gilead Sciences Balance Sheet Health
Financial Health criteria checks 3/6
Gilead Sciences has a total shareholder equity of $17.5B and total debt of $25.2B, which brings its debt-to-equity ratio to 144.3%. Its total assets and total liabilities are $56.3B and $38.8B respectively. Gilead Sciences's EBIT is $9.9B making its interest coverage ratio 17.7. It has cash and short-term investments of $5.5B.
Key information
144.3%
Debt to equity ratio
US$25.19b
Debt
Interest coverage ratio | 17.7x |
Cash | US$5.52b |
Equity | US$17.46b |
Total liabilities | US$38.84b |
Total assets | US$56.29b |
Recent financial health updates
Recent updates
A Look At Gilead Sciences After Its Recent Weakness
Jul 27Gilead Records Positive Phase III Results In HIV
Jun 22Is Gilead Sciences (NASDAQ:GILD) Using Too Much Debt?
Jun 13Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors
May 23We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation
May 02Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark
Apr 22Gilead Sciences: Some Signs Of An Impending Bottom
Apr 22Gilead Sciences: Realizing Financial Projections Is Key
Mar 20Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77
Mar 13Gilead's Business Development: The Good, The Bad, And The Spinning Kite Solution
Mar 01Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.77
Feb 28We Think Gilead Sciences' (NASDAQ:GILD) Solid Earnings Are Understated
Feb 15Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.77
Feb 13Gilead Sciences: Cheap For A Reason
Feb 10Gilead Sciences: The Sky Is Not Falling
Feb 01Financial Position Analysis
Short Term Liabilities: GILD's short term assets ($14.0B) exceed its short term liabilities ($13.0B).
Long Term Liabilities: GILD's short term assets ($14.0B) do not cover its long term liabilities ($25.8B).
Debt to Equity History and Analysis
Debt Level: GILD's net debt to equity ratio (112.7%) is considered high.
Reducing Debt: GILD's debt to equity ratio has increased from 120.3% to 144.3% over the past 5 years.
Debt Coverage: GILD's debt is well covered by operating cash flow (33.7%).
Interest Coverage: GILD's interest payments on its debt are well covered by EBIT (17.7x coverage).